Cargando…
S9.3d Antivirulence drug discovery to disarm Candida albicans with metabolites from myxobacteria.
S9.3 DRUG RESISTANCE IN EMERGING PATHOGENIC FUNGI, SEPTEMBER 23, 2022, 4:45 PM - 6:15 PM: Candida albicans is an opportunistic fungal pathogen. While nearly 40%-60% of humans are colonized harmlessly by C. albicans, prolonged use of antibiotics or an immune-compromised status can lead to mucosal or...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511645/ http://dx.doi.org/10.1093/mmy/myac072.S9.3d |